BioFabUSA Manufacturing Innovation Institute (regenerative tissue manufacturing)

Abstract

BioFabUSA advances state-of-the-art human tissue manufacturing innovations in cell and biomaterial processing, bioprinting, automation, and non-destructive testing technologies. BioFabUSA is establishing a collaboration to mature tissue-related technology across manufacturing readiness levels (MRL) 4-7, enabling post-delivery assurance of tissue identity, viability, function, and efficacy. This MII is assembling a diverse and currently fragmented collection of industry practices and institutional knowledge across many disciplines (e.g., cell biology, bioengineering, materials science, analytical chemistry, robotics, and quality assurance).

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2025
Source ID
7d4ee9fca4e64ecbc6a10c654de31d6c

Tags

Readers

  • Manufacturing Engineering.
  • Software Engineering.
  • Trauma Surgery or Emergency Medicine.

Technology Areas

  • AI & ML
  • AI & ML - DoD AI Strategy
  • Autonomy
  • Autonomy - Human-Robot Interaction
  • Biotechnology

Related Documents